Here are relevant reports on : investment-research-software-market
-
Specialty PACS Market by Type (Radiology, Orthopedics, Oncology, Pathology, Endoscopy, Women's Health), Deployment Model (On premise, Cloud), Component (Software, Service), End User (Hospital, Clinic, Diagnostic Centers, Research) - Global Forecasts to 2024
The global specialty PACS market size is projected to reach USD 3.5 billion in 2024, at a CAGR of 6.0%. Some of the prominent players offering in this market includes IBM Corporation (Merge Healthcare Incorporated) (US), McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).
- Published: September 2019
- Price: $ 4950
- TOC Available:
-
Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits), Software), Application (Research (Stem Cell), Clinical (Cancer)), End User (Hospital) - Global Forecast to 2033
The global flow cytometry market, valued at US$4.87 billion in 2024, stood at US$5.06 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2033, culminating in a forecasted valuation of US$9.85 billion by the end of the period. The major factors driving the growth in the flow cytometry market include advancements in technology, increasing adoption of flow cytometry products in clinical diagnostics, rising prevalence of chronic diseases, growing biopharmaceutical R&D, and the need for precision medicine.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Atomic Force Microscopy Market by Offering (AFMs, Probes, Software), Grade (Industrial, Research), Application (Semiconductors & Electronics, Material Science & Nanotechnology, Life Sciences & Biomedical) and Region - Global Forecast to 2030
The global atomic force microscopy market is expected to grow from USD 541.8 million in 2025 to USD 762.2 million by 2030, at a compound annual growth rate (CAGR) of 7.1% during the forecast period. The Key Players Park Systems (South Korea), Bruker (US), Hitachi High-Tech Corporation (Japan), Oxford Instruments (UK), and Semilab Inc. (Hungary).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Microarray Analysis Market by Product & Service (Consumables, Instrument, Software, Services), Type (DNA, Protein Microarray), Application (Research), End User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2023
The global microarray analysis market is projected to reach USD 5.52 billion by 2023, at a CAGR of 7.6%. The major factors driving the growth of this market are the increasing incidence of cancer, increasing funding for genomic and proteomic research, and growing application areas of microarrays. Key players in the microarray analysis market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Molecular Devices (US), PerkinElmer Inc. (US), Illumina, Inc. (US), GE Healthcare (US), and Bio-Rad Laboratories Inc. (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Immuno Oncology Assays Market Size, Share & Trends by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications (Lung, Breast, Colorectal, Bladder, Melanoma), Application (Research, Diagnostics) - Global Forecast to 2026
The size of global immuno oncology assays market in terms of revenue was estimated to be worth USD 4.4 billion in 2021 and is poised to reach USD 7.9 billion by 2026, growing at a CAGR of 12.5% from 2021 to 2026. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Robotic Dentistry Market by Product and Services (Standalone Robots, Robot Assisted Systems, Software, Services), Application (Implantology, Endodontics), End User (Dental Hospitals, Clinics, Dental Academic, Research Institute) & Region - Global Forecast to 2028
The global robotic dentistry market, valued at US$0.3 billion in 2022, stood at US$0.4 billion in 2023 and is projected to advance at a resilient CAGR of 17.3% from 2023 to 2028, culminating in a forecasted valuation of US$1.0 billion by the end of the period. The incidence of dental problems such as dental caries and the growing market for dental tourism in developing countries, rising incidences of oral health disorders, benefits of using robot systems and adoption of advanced technologies are major key drivers for the market.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Cell Sorting Market by Technology (FACS-based Droplet Sorting, MACS, Microfluidics), Product (Cell Sorters, Reagents, Consumables), Application (Research, Clinical), End User (Research Institutes, Biopharma Companies, Medical Schools) - Forecasts to 2021
The global cell sorting market is projected to grow at a CAGR of 7.0%. Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of this market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of this market.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) & Region - Global forecast to 2028
The global research antibodies & reagents market, valued at US$1.3 billion in 2022, stood at US$1.8 billion in 2023 and is projected to advance at a resilient CAGR of 45.6% from 2023 to 2028, culminating in a forecasted valuation of US$12.1 billion by the end of the period. The growth of this market is largely driven by an increase in research activity—especially in the life sciences industry—along with growing industry-academia collaborations are a primary growth driver for this market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecast to 2020
The global qPCR reagents market size is projected to grow at a CAGR of 7.7%. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market.
- Published: January 2016
- Price: $ 4950
- TOC Available:
-
Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020
The expression vectors market is expected to reach $317.1 Million by 2020 from $242.7 Million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. Major factors driving the growth of this market include the increasing demand of protein-based drugs (biologics); high prevalence of lifestyle diseases, infectious diseases, and genetic disorders; and increasing funding for protein research. On the other hand, high market consolidation, which increases entry barriers, and high cost of protein therapy are the major factors restraining the growth of this market.
- Published: June 2015
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
